alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### § 493.1351 General.

This subpart consists of the personnel requirements that must be met by laboratories performing moderate complexity testing, PPM procedures, high complexity testing, or any combination of these tests.

[60 FR 20049, Apr. 24, 1995]
Exhibit 32.1

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER

UNDER

SECTION 906 OF THE SARBANES-OXLEY ACT

THE COAST
DISTRIBUTION SYSTEM, INC.

Quarterly Report on Form 10-Q

for
the Quarter ended March 31, 2009

The undersigned, who is the Chief Executive Officer of The Coast Distribution System, Inc (the
Company), hereby certifies that (i) the Quarterly Report on Form 10-Q for the quarter ended March 31, 2009, as filed by the Company with the Securities and Exchange Commission (the Quarterly Report), to which this
Certification is an Exhibit, fully complies with the applicable requirements of Section 13(a) and 15(d) of the Exchange Act; and (ii) the information contained in this Quarterly Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.

Dated: May 15, 2009



/s/ JAMES MUSBACHJames MusbachPresident and Chief Executive OfficerA signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.
EXHIBIT 32.1





CERTIFICATION PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of Communication Intelligence Corporation (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Philip Sassower, Chairman and Chief Executive Officer, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002, that to the best of my knowledge:





(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





November 12, 2010





By: /s/Philip Sassower


Chairman and Chief Executive Officer
#### § 137.436 Will the decisions on appeal be available for the public to review?

Yes, all final decisions must be published for the Department under this subpart. Decisions can be found on the Department's website.
#### § 482.70 Definitions.

As used in this subpart, the following definitions apply:

*Adverse event* means an untoward, undesirable, and usually unanticipated event that causes death or serious injury, or the risk thereof. As applied to transplant programs, examples of adverse events include (but are not limited to) serious medical complications or death caused by living donation; unintentional transplantation of organs of mismatched blood types; transplantation of organs to unintended beneficiaries; and unintended transmission of infectious disease to a beneficiary.

*End-Stage Renal Disease (ESRD)* means that stage of renal impairment that appears irreversible and permanent, and requires a regular course of dialysis or kidney transplantation to maintain life.

*ESRD Network* means all Medicare-approved ESRD facilities in a designated geographic area specified by CMS.

*Heart-Lung transplant program* means a transplant program that is located in a hospital with an existing Medicare-approved heart transplant program and an existing Medicare-approved lung program that performs combined heart-lung transplants.

*Intestine transplant program* means a Medicare-approved liver transplant program that performs intestine transplants, combined liver-intestine transplants, or multivisceral transplants.

*Network organization* means the administrative governing body to the network and liaison to the Federal government.

*Pancreas transplant program* means a Medicare-approved kidney transplant program that performs pancreas transplants alone or subsequent to a kidney transplant as well as kidney-pancreas transplants.

*Transplant hospital* means a hospital that furnishes organ transplants and other medical and surgical specialty services required for the care of transplant patients.

*Transplant program* means an organ-specific transplant program within a transplant hospital (as defined in this section).

[51 FR 22042, June 17, 1986, as amended at 84 FR 51821, Sept. 30, 2019]
Certification 
 

I, Hamsa Shadaksharappa, certify that:

1. I have reviewed this quarterly report on Form 10-Q of IPALCO Enterprises, Inc. (the"registrant");

2. Based on my knowledge, this report does not contain any untrue statement of a material fact oromit to state a material fact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect to the period covered by thisreport; 

3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results of operationsand cash flows of the registrant as of, and for, the periods presented in this report; 

4. The registrant's other certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is being prepared;

(b) Evaluated the effectiveness of the registrant's disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on such evaluation; and

(c) Disclosed in this report any change in the registrant's internal control over financialreporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourthfiscal quarter in the case of an annual report) that has materially affected, or is reasonablylikely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant's auditors and the auditcommittee of registrant's board of directors (or persons performing the equivalentfunction):

(a) All significant deficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adversely affect the registrant'sability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have asignificant role in the registrant's internal control over financial reporting.

Date:	May 11, 2004	
/s/ Hamsa Shadaksharappa	

Hamsa Shadaksharappa

Senior Vice President - Financial Services, Chief FinancialOfficer and Secretary
Editorial Note on Part 460
Editorial Note: Nomenclature changes to part 460 appear at 67 FR 61504, Oct. 1, 2002.

§ 460.92 Required services. ( a ) The PACE benefit package for all participants, regardless of the source of payment, must include the following: ( 1 ) All Medicare-covered services.
( 2 ) All Medicaid-covered services, as specified in the State's approved Medicaid plan.
( 3 ) Other services determined necessary by the interdisciplinary team to improve and maintain the participant's overall health status.
( b ) Decisions by the interdisciplinary team to provide or deny services under paragraph (a) of this section must be based on an evaluation of the participant that takes into account: ( 1 ) The participant's current medical, physical, emotional, and social needs; and
( 2 ) Current clinical practice guidelines and professional standards of care applicable to the particular service.
[86 FR 6132, Jan. 19, 2021]
#### SAMUEL P. MILAZZO *v.*BARRY S. SCHWARTZ ET AL.

The defendants’ petition for certification for appeal from the Appellate Court, 44 Conn. App. 402 (AC 15579), is denied.

*927
      *Dana P. Lonergan,*in support of the petition.

*Robert R. Petrucelli,*in opposition.

Decided April 17, 1997
| Dated:      November 15, 2010 |        | /s/ Dwight      Babcock                      |   |
|-------------------------------|--------|---------------------------------------------------|--------|
|                          |   | DWIGHT      BABCOCK                               |   |
|                          |   | CHIEF      EXECUTIVE OFFICER                      |   |
|                          |   | (Principal      Executive Officer)                |   |
|                          |   |                                              |   |
|                          |   |                                              |   |
| Dated:      November 15, 2010 |   | /s/ Brien      Ragle                         |   |
|                          |   | BRIEN      RAGLE                                  |   |
|                          |   | CONTROLLER                                        |   |
|                          |   | (Principal      Financial and Accounting Officer) |   |

----
****

This chart presents 1997 Nebraska exports to the Newly IndependentStates of the former Soviet Union.  Data used to create the chart werecollected by the Bureau of the Census, U.S. Department of Commerce,with further analysis by the University of Massachusetts,Massachusetts Institute for Social and Economic Research (MISER). Formore information call BISNIS at (202) 482-4655 or visit the MISER websiteat www.umass.edu/miser.
'96 export data for Nebraska
'95 export data for Nebraska
Return to USA Export Map
Return to BISNIS Home Page
§ 488.1115 Surveyor qualifications and prohibition of conflicts of interest. ( a ) *Minimum qualifications.* Surveyors must meet minimum qualifications prescribed by CMS. Before any accrediting organization, State or Federal surveyor may serve on a hospice survey team (except as a trainee), he/she must have successfully completed the relevant CMS-sponsored Basic Hospice Surveyor Training Course, and additional training as specified by CMS.
( b ) *Disqualifications.* Surveyor(s) must disclose actual or perceived conflicts of interest prior to participating in a hospice program survey and be provided the opportunity to recuse themselves as necessary. Any of the following circumstances disqualifies a surveyor from surveying a particular hospice program: ( 1 ) The surveyor currently serves, or, within the previous 2 years has served, with the hospice program to be surveyed as one of the following: ( i ) A direct employee.
( ii ) An employment agency staff at the hospice program.
( iii ) An officer, consultant, or agent for the hospice program to be surveyed concerning compliance with conditions of participation specified in or in accordance with sections 1861(dd) of the Act.
( 2 ) The surveyor has a financial interest or an ownership interest in the hospice program to be surveyed.
( 3 ) The surveyor has an immediate family member, as defined at § 411.351 of this chapter, who has a financial interest or an ownership interest with the hospice program to be surveyed.
( 4 ) The surveyor has an immediate family member, as defined at § 411.351 of this chapter, who is a patient of the hospice program to be surveyed.
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 04-1776

NEWPORT NEWS SHIPBUILDING AND DRY DOCK

COMPANY,

 Petitioner,

 versus

ARCHIE T. SPIERS; DIRECTOR, OFFICE OF WORKERS'

COMPENSATION PROGRAMS, UNITED STATES

DEPARTMENT OF LABOR,

 Respondents.

On Petition for Review of an Order of the Benefits Review Board.

(03-624-BLA)

Submitted: December 13, 2004 Decided: January 14, 2005

Before WILLIAMS, MICHAEL, and MOTZ, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Jonathan H. Walker, MASON, MASON, WALKER & HEDRICK, PC, Newport

News, Virginia, for Petitioner. Howard M. Radzely, Solicitor of

Labor, Donald S. Shire, Associate Solicitor, Mark A. Reinhalter,

Counsel for Longshore, Kathleen H. Kim, UNITED STATES DEPARTMENT OF

LABOR, Washington, D.C., for Respondent Director.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
- 2 -

PER CURIAM:

Newport News Shipbuilding and Dry Dock Company seeks

review of the Benefits Review Board’s decision and order affirming

the administrative law judge’s denial of its request for relief

from continuing compensation liability pursuant to 33 U.S.C.

§ 908(f) (2000). Our review of the record discloses that the

Board’s decision is based upon substantial evidence and is without

reversible error. Accordingly, we affirm on the reasoning of the

Board. See Newport News Shpbldg. and Dry Dock Co. v. Spiers, No.

03-624-BLA (BRB May 7, 2004). We dispense with oral argument

because the facts and legal contentions are adequately presented in

the materials before the court and argument would not aid the

decisional process.

AFFIRMED
§ 447.522 Optional coverage of investigational drugs and other drugs not subject to rebate. ( a ) Medicaid coverage of investigational drugs may be provided at State option under section 1905(a)(12) of the Act when such drug is the subject of an investigational new drug application (IND) that has been allowed by FDA to proceed.
( b ) A State agency electing to provide coverage of an investigational drug must include in its State plan a description of the coverage and payment for such drug.
( c ) The State plan must indicate that any reimbursement for investigational drugs by the State are consistent with FDA regulations at 21 CFR part 312 if they are to be eligible to receive FFP for these drugs.
( d ) Medicaid coverage of other drugs may be provided at State option under section 1905(a)(12) of the Act provided that they are not eligible to be covered as covered outpatient drugs in the Medicaid Drug Rebate program.
( e ) Investigational drugs and other drugs are not subject to the rebate requirements of section 1927 of the Act provided they do not meet the definition of a covered outpatient drug as set forth in section 1927(k) of the Act.
Electronically Filed

Intermediate Court of Appeals

CAAP-15-0000894

28-JUN-2017

08:15 AM
Home1988 Treaties and Agreements...Panama (88-222) – Agreement on Law Enforcement of Support Obligations

# 									Panama (88-222) – Agreement on Law Enforcement of Support Obligations							

TIAS

Office of Treaty Affairs

February 22, 1988

Private International Law: Enforcement of Support Obligations

Agreement effected by exchange of notes, with annexes, at Panama February 22, 1988; entered into force February 22, 1988.
Download Agreement						 [4 MB]

Tags

Law EnforcementPanamaTreatiesTreaties and International Agreements

Back to Top
* Pursuant to Local Rule 47.5, the court has determined

that this opinion should not be published and is not precedent except under the limited circumstances set forth in Local Rule 47.5.4. UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

_____________________________

No. 96-30575

_____________________________

VYRON L. BROWN,

Plaintiff-Appellant,

versus

GEORGIA COMMISSIONER OF INSURANCE, ET AL.

Defendants,

INTEGON INDEMNITY CORPORATION Defendant-Appellee.

_________________________________________________________________

Appeal from the United States District Court for the Western District of Louisiana

( 95-CV-267 )

_________________________________________________________________ December 26, 1996 Before SMITH, DUHÉ, and BARKSDALE, Circuit Judges.

PER CURIAM * :

Vyron Brown brought this action for damages under a bid bond

which Integon had issued to Br own so that Brown could bid on a

government c ontract. Because Brown owed Integon approximately

$3500.00, guaranteed by a promissory note, Integon refused to issue

further bonds necessary for Brown to beg in work. Integoncounterclaimed on the promissory note and moved f or summary

j udgment on Brown’s contract claim. The district court granted

summary judgment dismissing Brown’s contract claim. But, neither

the Order Granting Summary Judgment nor the ensuing Judgment

disposed of Integon’s counterclaim. The district court made no

F ED

. R. C IV

. P. 54(b) “express determination th a t there is no just

reason for delay”, allowing appeal of the contract claim before the

counterclaim was addressed.

In the absence of an express determination that there is no
just reason for delay, the dismis sal of complaint by summary

judgment, which doe s not dispose of a counterclaim, does not

constitute an appealable final order. B elmont Place Associates v.

Blyth, Eastman, Dillon and Co., Inc , 565 F.2d 1322, 1322-23 (5th

Cir. 1978); see also Johnson v. McDole
, 526 F.2d 710 (5th Cir.

1976). The summary judgment order acknowledges Integon’s

counterclaim, but does not dispose of it. We therefore have no

jurisdiction over this appeal.

DISMISSED
ex10_2.htm


     AMENDMENT
TO PURCHASE AGREEMENT 

     

     This
Amendment to Purchase Agreement entered into as of February 12, 2009 by and
between BLUE EARTH SOLUTIONS TENNESSEE Inc., a Tennessee corporation
("Purchaser") and THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA, A New York
corporation, successor by merger to Berkshire Life Insurance Company, a
Massachusetts corporation ("Seller"); 

     

    WITNESSETH:

     

     WHEREAS, Seller and Purchaser
entered into that certain Purchase and Sale Agreement, effectively dated January
8, 2009 (the "Contract"); and 

     

     WHEREAS, Purchaser and Seller
desire to continue with the Contract subject to the changes thereto hereinafter
set forth; 

     

     NOW, THEREFORE, for and in
consideration of the premises hereof and of other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged,
Purchaser and Seller do hereby covenant, stipulate and agree as
follows: 

     

    
      	
               1.   

            	
              Closing
      Date : Seller and Purchaser agree and recognize that the Closing
      date for this transaction shall be on or before March 31,
      2009. 

            


    

     

    
      	
               2.   

            	
               All
      other terms and conditions as set forth in the Agreement shall remain in
      full force and effect. 

            


    

     

    
      	
               3.   

            	
               This
      Amendment may be executed in multiple counterparts, each of which shall be
      deemed an original. 

            


    

     

    
      	
               4.   

            	
               The
      Agreement, as modified herein, is hereby ratified and confirmed by the
      parties as binding upon each of them and enforceable against them in
      accordance with its terms and
conditions. 

            


    

     

     IN
WITNESS WHEREOF, the parties have executed this Amendment to Purchase and Sale
Agreement as of the dates set forth below their respective
signatures. 

     

    
      	
               PURCHASER: 

            
	
               BLUE
      EARTH SOLUTIONS TENNESSEE INC., 

               a
      Tennessee corporation 

            
	  
      
	
               By:
      /s/ James Cohen
      Jr. 

            
	
               Name:
      James Cohen Jr. 

            
	
               Title:
      Vice President 

            
	  
      
	
               SELLER: 

            
	
               THE
      GUARDIAN LIFE INSURANCE COMPANY OF AMERICA, a New York corporation,
      successor by merger to Berkshire Life Insurance Company, a Massachusetts
      corporation 

            
	  
      
	
               By:
      /s/ Robert
      LoCascio 

            
	
               Name
      Robert LoCascio 

            
	
               Title:
      Sr. Director
EPA Form 5900-85

 OMB No. 2060-0336, Approval Expires 06/30/2015

POTENTIAL TO EMIT (PTE)

For each unit with emissions that count towards applicability, list the emissions unit ID and the PTE for 

the air pollutants listed below and sum them up to show totals for the facility. You may find it helpful to 

complete form EMISS before completing this form. Show other pollutants not listed that are present in 

major amounts at the facility on attachment in a similar fashion. You may round values to the nearest 

tenth of a ton. Also report facility totals in section J of form GIS. 

 

PTE

Emissions Unit 

ID

Regulated Air Pollutants and Pollutants for which the Source is Major

(tons/yr)

PM10 PM2.5 NOx SO2 H2SO4 CO VOC Lead HAP

Refer to Section 3 and Appendix B of the attached application.
41332.

#### ADAIR REALTY & LOAN COMPANY v. WILLIAMS BROTHERS LUMBER COMPANY et al.

Bell, Presiding Judge.

This is an appeal objecting to the judgment of the trial court refusing to award attorney’s fees on a promissory note.

*Code Ann.*§ 20-506 authorizes collection, as a part of the debt, of contractual obligations to pay attorney’s fees on the creditor’s giving 10 days notice to the debtor. If the debtor pays *17the principal and interest in full during that 10 day period the attorney’s fees are not collectible. The obligation to pay attorney’s fees is only a contingent liability and the debtor is not bound to pay them until there is a full compliance with conditions precedent stated in the statute. *Strickland v. Williams,*215 Ga. 175, 177 (2) (109 SE2d 761). These conditions precedent include those that the collection be made by an attorney at law, that the debt has matured, that the contract included an obligation to pay attorney’s fees, and that the required 10 days notice has been given and the period has expired without payment of the principal and interest in full.

Submitted May 5, 1965

Decided May 20, 1965

Rehearing denied June 21, 1965.

*Smith, Bing el, Martin & Lowe, Hoke Smith,*for plaintiff in error.

*O. E. Williams, Sam G. Dettelbach, Mitchell, Clarke, Pate &*
      *18
      *Anderson, Paul H. Anderson, Claude Hambrick, Jr., George Ricketson, William, J. Porter, Jr.,*contra.

*17In the case at bar the notice given by the holder of the note to the maker is deficient in that the alleged notice did not contain the statutory *requirement informing*the maker that she had ten days from the receipt of the notice to pay the principal and interest of the note without obligating herself for the payment of attorney’s fees. “By the terms of *Code (Ann. Supp.)*§ 20-506, attorney’s fees, for which provision is made in a promissory note, are not collectible unless it be alleged and proved that after maturity the holder of the note notified the person sought to be bound thereon that he had ten days from the receipt of such notice to pay the principal and interest without attorney’s fees; . . .” *Stone v. Colonial Credit Co.,*93 Ga. App. 348, 349 (3) (91 SE2d 835). See *Walton v. Johnson,*213 Ga. 108, 111 (3) (97 SE2d 310). The notice here while otherwise substantially complying with the requirements of the statute, merely advised the maker that, if she did not make arrangements to pay the note in full within ten days from the date of the notice, rather than from the date of its receipt by her, plaintiff would claim attorney’s fees provided for in the note.

The judgment of the trial court disallowing attorney’s fees to appellant as a part of the indebtedness is affirmed.

*Judgment affirmed.*

*Frankum and Hall, JJ., concur.*